Начало › Рак на гърдата › Вирджиния › Richmond
Клинични проучвания за Рак на гърдата в Richmond, VA
26 проучвания за Рак на гърдата търсят участници в обекти в и около Richmond (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
The Vanguard Study: Testing a New Way to Screen for Cancer
Набиране на участнициЗдравите доброволци са добре дошли
- VCU Massey Cancer Center at Stony Point, Richmond
- VCU Massey Comprehensive Cancer Center, Richmond
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Набиране на участнициФаза 3
- Bon Secours Virginia Health System, Midlothian · на 11 мили
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Набиране на участнициНаблюдателно проучванеЗдравите доброволци са добре дошли
- Bon Secours Richmond Community Hospital, Richmond
- Bon Secours Saint Mary's Hospital, Richmond
- Bon Secours Cancer Institute at Reynolds Crossing, Richmond
- и още 3
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Набиране на участнициФаза 2
- Virginia Cancer Institute, Richmond
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Набиране на участнициФаза 3
- VCU Health Adult Outpatient Pavillion ( Site 0070), Richmond
- Bon Secours St. Francis Medical Center-Oncology Research ( Site 0015), Midlothian · на 11 мили
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Набиране на участнициФаза 3
- Research Site, Midlothian · на 11 мили
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Набиране на участнициФаза 3
- Bon Secours Cancer Institute at St. Francis ( Site 0048), Midlothian · на 11 мили
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Набиране на участнициФаза 3
- Clinical Trial Site, Midlothian · на 11 мили
Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab
Набиране на участници
- Adult Outpatient Pavilion, Richmond
- Cellular Immunotherapies and Transplant Department, Richmond
- VCU Health at Stony Point, Richmond
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Набиране на участнициФаза 3
- Bon Secours Cancer Institute at St. Mary's, Richmond
- Bon Secours Cancer Institute at Memorial Regional, Mechanicsville · на 6 мили
- Bon Secours St. Francis Medical Center, Midlothian · на 11 мили
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Набиране на участнициФаза 3
- Virginia Cancer Institute, Richmond
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
Набиране на участнициФаза 3
- Research Site, Midlothian · на 11 мили
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Набиране на участнициФаза 3
- Bon Secours Richmond Community Hospital, Richmond
- Bon Secours Saint Mary's Hospital, Richmond
- Bon Secours Cancer Institute at Reynolds Crossing, Richmond
- и още 4
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Набиране на участнициФаза 2/3
- Bon Secours St. Francis Medical Center, Midlothian · на 11 мили
E-Mindfulness Approaches for Living After Breast Cancer
Набиране на участнициФаза 3
- Bon Secours Richmond Community Hospital, Richmond
- Bon Secours Saint Mary's Hospital, Richmond
- Virginia Cancer Institute, Richmond
- и още 4
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
Набиране на участници
- Virgina Community University Massey Comprehensive Cancer Center, Richmond
Study to Evaluate the Feasibility of Twice Daily Use of Topical Azelaic Acid in Breast Cancer Patients Undergoing Radiation
Набиране на участнициФаза 1
- Virginia Commonwealth University, Richmond
Pre-Operative Window of ET to Inform RT Decisions (POWER II)
Набиране на участнициФаза 3
- Virginia Commonwealth University, Richmond
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Набиране на участнициФаза 3
- Bon Secours St. Francis Medical Oncology Center, Midlothian · на 11 мили
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Набиране на участнициФаза 3
- Bon Secours Cancer Institute at Memorial Regional Medical Center, Mechanicsville · на 6 мили
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Набиране на участнициФаза 3
- Bon Secours Saint Mary's Hospital, Richmond
- Bon Secours Cancer Institute at Reynolds Crossing, Richmond
- Bon Secours Memorial Regional Medical Center, Mechanicsville · на 6 мили
- и още 1
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Набиране на участнициНаблюдателно проучване
- VCU Massey Cancer Center at Stony Point, Richmond
- Virginia Commonwealth University/Massey Cancer Center, Richmond
PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients
Набиране на участнициНаблюдателно проучване
- VCU Massey Comprehensive Cancer Center, Richmond
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Набиране на участнициНаблюдателно проучване
- VCU Massey Comprehensive Cancer Center, Richmond
- Bon Secours Cancer Institute at St. Francis, Midlothian · на 11 мили
ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy
Набиране на участнициФаза 2
- Virginia Commonwealth University, Richmond
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
Набиране на участнициЗдравите доброволци са добре дошли
- Virginia Commonwealth University, Richmond
Проучвания за Рак на гърдата в други градове
- New York City, NY136 проучвания
- Houston, TX126 проучвания
- Boston, MA112 проучвания
- Nashville, TN81 проучвания
- Los Angeles, CA73 проучвания
- Edison, NJ68 проучвания
- St. Louis, MO64 проучвания
- Queens, NY64 проучвания
- Durham, NC64 проучвания
- Chicago, IL59 проучвания
- Philadelphia, PA56 проучвания
- Dallas, TX55 проучвания
Други проучвания в Richmond
- Рак на белия дроб с недребноклетъчен тип25 проучвания
- Рак на простатата19 проучвания
- Сърдечна недостатъчност16 проучвания
- Рак на белия дроб14 проучвания
- Сърдечно-съдово заболяване13 проучвания
- Колоректален рак13 проучвания
- Стеатотично чернодробно заболяване12 проучвания
- Остра миелоидна левкемия12 проучвания
- Метастатичен рак12 проучвания
- Плоскоклетъчен карцином на главата и шията12 проучвания
- Меланом11 проучвания
- Затлъстяване11 проучвания
От ClinicalTrials.gov, данни към 6.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.